NCT07180407

Brief Summary

BACKGROUND: ICU survivors may experience serious psychological, physical and cognitive impairments following ICU admission, collectively termed Post Intensive Care Syndrome (PICS). Persistent pain is an underrecognized component of PICS. Previous research has shown that persistent pain is a profound clinical challenge in ICU survivors, however, research demonstrates conflicting results. Furthermore, no studies have examined the prevalence of persistent pain in ICU survivors in a contemporary Danish ICU setting. OBJECTIVES: We aim to examine the clinical trajectory, risk factors, and pathophysiology of persistent pain in ICU survivors in Denmark. DESIGN AND SAMPLE SIZE: The study is designed as a multicenter, prospective, inception cohort study with clinical follow-up. Based on the pre-study sample size calculation, 800 patients will be included. Patients will be contacted by telephone 90 days and 180 days after ICU discharge, and a series of questionnaires regarding pain, sleep quality, affective state and quality of life will be completed. A subgroup of patients will undergo a detailed clinical examination including quantitative sensory testing between 180-365 days after ICU discharge. POPULATION: Patients will be recruited from 4 Danish ICU departments. Inclusion criteria include adult patients (18 years of age), acute admission to the ICU, and an ICU admission of a minimum of 48 hours. OUTCOMES: The primary outcome is the prevalence of pain assessed by the Brief Pain Inventory (BPI) at 90 and 180 days after ICU discharge. Secondary outcomes include additional detailed descriptions of pain and daily activity, sleep quality, affective state, quality of life, treatment- and patient-related risk factors, and biomarkers associated with development of persistent pain. Substudies: \- QST substudy: 80 participants (40 with pain and 40 without pain) recruited from the main cohort will undergo Quantative Somatosensory Testing (QST). The objectives are first, to delineate somatosensory profiles of ICU survivors with and without pain, and second, to examine the presence of neuropathic pain in ICU survivors.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
13mo left

Started Sep 2025

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress37%
Sep 2025Jun 2027

First Submitted

Initial submission to the registry

July 15, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 18, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

September 23, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

December 2, 2025

Status Verified

September 1, 2025

Enrollment Period

1.3 years

First QC Date

July 15, 2025

Last Update Submit

November 29, 2025

Conditions

Keywords

intensive care unitschronic painsleep disorderanxiety and depressionicu survivors

Outcome Measures

Primary Outcomes (1)

  • Prevalence of pain

    Patients are defined as having pain if they answer "yes" to question number 1 in the Brief Pain Inventory - Short Form

    180 day follow-up

Secondary Outcomes (9)

  • Brief Pain Inventory - Short Form (BPI-SF)

    At follow-up at 90 and 180 days

  • Incidence of new-onset persistent pain after ICU discharge

    at 90 and 180 days follow-up

  • Quality of life measured by EuroQol-5-domain 5-level (EQ-5D-5L)

    at 90 and 180 days

  • The Single Item Sleep Quality Scale (SQS)

    at 90 and 180 days

  • Hospital Anxiety and Depression Scale (HADS)

    at 90 and 180 days

  • +4 more secondary outcomes

Other Outcomes (7)

  • The Short Physical Performance Battery (SPPB)

    between 180 days followup and 360 days.

  • PainDETECT (PD-Q)

    between 180 days followup and 360 days

  • QST outcomes

    between 180 days followup and 360 days

  • +4 more other outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to the ICU

You may qualify if:

  • Adult ICU patients ≥18 years of age
  • Acute admission to the ICU
  • ICU length of stay of at least 48 hours

You may not qualify if:

  • Patients transferred from a non-participating ICU
  • Patients with pre-planned admission to the ICU e.g., following elective surgery
  • Patients unable to complete questionnaires, including those who are unable to understand or speak Danish, or patients with severe cognitive deficits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Aalborg University Hospital

Aalborg, 9000, Denmark

NOT YET RECRUITING

Zealand University Hospital

Køge, 4600, Denmark

RECRUITING

Zealand University Hospital

Nykøbing Falster, 4800, Denmark

RECRUITING

Zealand University Hospital

Roskilde, 4000, Denmark

RECRUITING

MeSH Terms

Conditions

Chronic PainSomatoform DisordersSleep Wake DisordersAnxiety DisordersDepression

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersNervous System DiseasesBehavioral SymptomsBehavior

Central Study Contacts

Bennedikte K Madsen, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 15, 2025

First Posted

September 18, 2025

Study Start

September 23, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

December 2, 2025

Record last verified: 2025-09

Locations